{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:54:48Z","timestamp":1791172488434,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.pupt.2026.102452","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:18:04Z","timestamp":1790896684000},"page":"102452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Belumosudil improves experimental pulmonary fibrosis via the ROCK2\/Smad3\/CTGF pathway"],"prefix":"10.1016","volume":"95","author":[{"given":"Dexin","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanglin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2026.102452_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110017","article-title":"Comparative transcriptome profile of mouse macrophages treated with the RhoA\/Rock pathway inhibitors Y27632, Fingolimod (Gilenya), and Rezurock (Belumosudil, SLx-2119)","volume":"118","author":"Subuddhi","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.pupt.2026.102452_bib2","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an Official ATS\/ERS\/JRS\/ALAT Clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9","key":"10.1016\/j.pupt.2026.102452_bib3","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1164\/rccm.202311-2108ED","article-title":"Gazing into the proteomic crystal ball: predicting survival in idiopathic pulmonary fibrosis","volume":"209","author":"Lee","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.pupt.2026.102452_bib4","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143226","article-title":"Immune dysregulation as a driver of idiopathic pulmonary fibrosis","volume":"131","author":"Shenderov","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.pupt.2026.102452_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199105","article-title":"Role of ROCK signaling in virus replication","volume":"329","author":"Kumar","year":"2023","journal-title":"Virus Res."},{"issue":"4","key":"10.1016\/j.pupt.2026.102452_bib6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1165\/rcmb.2023-0401OC","article-title":"Novel small-molecule ROCK2 inhibitor GNS-3595 attenuates pulmonary fibrosis in preclinical studies","volume":"71","author":"Hwang","year":"2024","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"20","key":"10.1016\/j.pupt.2026.102452_bib7","doi-asserted-by":"crossref","first-page":"21892","DOI":"10.1021\/acs.jmedchem.5c02233","article-title":"Identification of novel Imidazo[1,2-b]pyridazine derivatives as selective ROCK2 inhibitors for the treatment of pulmonary fibrosis","volume":"68","author":"Cao","year":"2025","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.pupt.2026.102452_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/bcpt.13924","article-title":"Sapanisertib attenuates pulmonary fibrosis by modulating Wnt5a\/mTOR signalling","volume":"133","author":"Xu","year":"2023","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.pupt.2026.102452_bib9","article-title":"Tirbanibulin Attenuates Pulmonary Fibrosis by modulating Src\/STAT3 signaling","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"7835","key":"10.1016\/j.pupt.2026.102452_bib10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.pupt.2026.102452_bib11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2147\/TCRM.S81141","article-title":"Role of pirfenidone in the management of pulmonary fibrosis","volume":"13","author":"Meyer","year":"2017","journal-title":"Therapeut. Clin. Risk Manag."},{"issue":"9","key":"10.1016\/j.pupt.2026.102452_bib12","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.6061\/clinics\/2012(09)10","article-title":"Increased fibroblast telomerase expression precedes myofibroblast \u03b1-smooth muscle actin expression in idiopathic pulmonary fibrosis","volume":"67","author":"Waisberg","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"issue":"2","key":"10.1016\/j.pupt.2026.102452_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/14656566.2018.1425681","article-title":"Nintedanib for the treatment of idiopathic pulmonary fibrosis","volume":"19","author":"Varone","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.pupt.2026.102452_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1444964","article-title":"Macrophage polarization and its impact on idiopathic pulmonary fibrosis","volume":"15","author":"Ge","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.pupt.2026.102452_bib15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12964-024-01557-2","article-title":"The role of macrophage polarization and cellular crosstalk in the pulmonary fibrotic microenvironment: a review","volume":"22","author":"Zhou","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.pupt.2026.102452_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114345","article-title":"Modulation of M1 and M2 macrophage polarization by metformin: implications for inflammatory diseases and malignant tumors","volume":"151","author":"Jafarzadeh","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.pupt.2026.102452_bib17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3892\/br.2014.323","article-title":"Rho\/Rock cross-talks with transforming growth factor-\u03b2\/Smad pathway participates in lung fibroblast-myofibroblast differentiation","volume":"2","author":"Ji","year":"2014","journal-title":"Biomed Rep"},{"key":"10.1016\/j.pupt.2026.102452_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108823","article-title":"ROCK2, a critical regulator of immune modulation and fibrosis has emerged as a therapeutic target in chronic graft-versus-host disease","volume":"230","author":"Zanin-Zhorov","year":"2021","journal-title":"Clin. Immunol."},{"issue":"8","key":"10.1016\/j.pupt.2026.102452_bib19","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1513\/pats.200605-125SF","article-title":"Smad3 signaling involved in pulmonary fibrosis and emphysema","volume":"3","author":"Gauldie","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"8021","key":"10.1016\/j.pupt.2026.102452_bib20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41586-024-07660-1","article-title":"Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis","volume":"631","author":"Tsukui","year":"2024","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.pupt.2026.102452_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116064","article-title":"Connective tissue growth factor in idiopathic pulmonary fibrosis: breaking the Bridge","volume":"23","author":"Effendi","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553926000453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553926000453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:42:08Z","timestamp":1791171728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553926000453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":21,"alternative-id":["S1094553926000453"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2026.102452","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Belumosudil improves experimental pulmonary fibrosis via the ROCK2\/Smad3\/CTGF pathway","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2026.102452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102452"}}